Detalhe da pesquisa
1.
Radiation Reveal: Moving from research engagement to involvement.
Br J Cancer
; 130(10): 1593-1598, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38615107
2.
Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans-Atlantic, multicenter cross-sectional cohort study.
Pediatr Blood Cancer
; 70(8): e30412, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37249325
3.
Bladder function after conservative surgery and high-dose rate brachytherapy for bladder-prostate rhabdomyosarcoma.
Pediatr Blood Cancer
; 69(8): e29574, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35044080
4.
Parents' responses to prognostic disclosure at diagnosis of a child with a high-risk brain tumor: Analysis of clinician-parent interactions and implications for clinical practice.
Pediatr Blood Cancer
; 68(3): e28802, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33226200
5.
A phase IIa trial of molecular radiotherapy with 177-lutetium DOTATATE in children with primary refractory or relapsed high-risk neuroblastoma.
Eur J Nucl Med Mol Imaging
; 47(10): 2348-2357, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32157433
6.
How rapid advances in imaging are defining the future of precision radiation oncology.
Br J Cancer
; 120(8): 779-790, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30911090
7.
Outcome of localized liver-bile duct rhabdomyosarcoma according to local therapy: A report from the European Paediatric Soft-Tissue Sarcoma Study Group (EpSSG)-RMS 2005 study.
Pediatr Blood Cancer
; 66(7): e27725, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30920113
8.
Outcome and prognostic factors in pediatric malignant peripheral nerve sheath tumors: An analysis of the European Pediatric Soft Tissue Sarcoma Group (EpSSG) NRSTS-2005 prospective study.
Pediatr Blood Cancer
; 66(10): e27833, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31241238
9.
Psychosocial well-being of long-term survivors of pediatric head-neck rhabdomyosarcoma.
Pediatr Blood Cancer
; 66(2): e27498, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30318743
10.
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.
Lancet Oncol
; 19(12): 1617-1629, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30442501
11.
Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial.
Lancet Oncol
; 19(8): 1061-1071, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29941280
12.
Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study.
Cancer
; 124(5): 1016-1024, 2018 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29211298
13.
Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissue.
Eur J Nucl Med Mol Imaging
; 45(3): 402-411, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29043399
14.
New UK guidelines for differentiated thyroid cancer in children.
Br J Surg
; 109(10): 1021-1022, 2022 09 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35918803
15.
Impact of induction chemotherapy, hyperfractionated accelerated radiotherapy and high-dose thiotepa on brain volume loss and functional status of children with primitive neuroectodermal tumour.
Pediatr Blood Cancer
; 64(11)2017 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-28509337
16.
Paratesticular rhabdomyosarcoma in children and adolescents-Outcome and patterns of relapse when utilizing a nonsurgical strategy for lymph node staging: Report from the International Society of Paediatric Oncology (SIOP) Malignant Mesenchymal Tumour 89 and 95 studies.
Pediatr Blood Cancer
; 64(9)2017 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-28205365
17.
An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma.
BMC Cancer
; 16: 621, 2016 08 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27515310
18.
The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy and Response Directed High Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy).
Pediatr Blood Cancer
; 62(12): 2132-9, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26274622
19.
Paediatric radiotherapy in the United Kingdom: an evolving subspecialty and a paradigm for integrated teamworking in oncology.
Br J Radiol
; 97(1153): 21-30, 2024 Jan 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38263828
20.
Brachytherapy for rhabdomyosarcoma: Survey of international clinical practice and development of guidelines.
Radiother Oncol
; 195: 110273, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38588921